Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ANPEP | P15144 | 2/20 | 0.40 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.40 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1149281 | 1.00 | TSHR (0.45) | TSHRALDH1A1POLBCYP1A2CYP2C19 | |
| SCHEMBL6350811 | 0.81 | PKM (0.41) | TSHRALDH1A1POLBCYP1A2CYP2C19 | |
| SCHEMBL19025403 | 0.79 | ANPEP (0.44) | TSHRALDH1A1POLBCYP1A2CYP2C19 | |
| SCHEMBL105518 | 0.76 | TSHR (0.50) | TSHRPOLBCYP1A2CYP2C19CYP3A4 | |
| SCHEMBL108917 | 0.76 | TRPA1 (0.50) | TSHRPOLBCYP1A2CYP2C19CYP3A4 | |
| SCHEMBL1149370 | 0.76 | MMP12 (0.45) | TSHRALDH1A1POLBCYP1A2CYP2C19 | |
| SCHEMBL30146557 | 0.75 | TDP1 (0.52) | TSHRALDH1A1CYP3A4SMN1; SMN2HPGD | |
| SCHEMBL30146580 | 0.75 | TDP1 (0.52) | TSHRALDH1A1CYP3A4SMN1; SMN2HPGD | |
| SCHEMBL7268763 | 0.75 | TDP1 (0.52) | TSHRALDH1A1CYP3A4SMN1; SMN2HPGD | |
| SCHEMBL8977879 | 0.74 | ANPEP (0.43) | TSHRALDH1A1CYP1A2CYP2C19SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9901913-B2 | Catalyst and method for producing optically active anti-1,2-nitroalkanol compound | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 2018-02-27 | — | — | US | disclosed |
| US-9901913-B2 | Catalyst and method for producing optically active anti-1,2-nitroalkanol compound | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 2018-02-27 | — | — | US | disclosed |
| US-20150375219-A1 | Catalyst and Method for Producing Optically Active Anti-1,2-Nitroalkanol Compound | Microbial Chemistry Rsearch Fiundation (JP) | 2015-12-31 | — | — | US | disclosed |
| US-20150375219-A1 | Catalyst and Method for Producing Optically Active Anti-1,2-Nitroalkanol Compound | Microbial Chemistry Rsearch Fiundation (JP) | 2015-12-31 | — | — | US | disclosed |
| EP-2957342-A1 | CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE ANTI-1,2-NITROALKANOL COMPOUND | Microbial Chemistry Research Foundation (JP) | 2015-12-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150375219-A1 | Catalyst and Method for Producing Optically Active Anti-1,2-Nitroalkanol Compound | SCN1A, SCN1B, NOS1 | TSHR 3783/4885ALDH1A1 918/4885POLB 606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.